Eric-Paul Pâques

856 total citations
14 papers, 722 citations indexed

About

Eric-Paul Pâques is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Eric-Paul Pâques has authored 14 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 7 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in Eric-Paul Pâques's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Blood properties and coagulation (3 papers). Eric-Paul Pâques is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Protease and Inhibitor Mechanisms (7 papers) and Blood properties and coagulation (3 papers). Eric-Paul Pâques collaborates with scholars based in Germany and Belgium. Eric-Paul Pâques's co-authors include S Baudner, G. Müller‐Berghaus, Désiré Collen, Paul Declerck, M De Mol, Marie‐Christine Alessi, Klaus T. Preissner, N. Heimburger, Gerhard Dickneite and Jürgen Römisch and has published in prestigious journals such as Journal of Biological Chemistry, FEBS Letters and Journal of Investigative Dermatology.

In The Last Decade

Eric-Paul Pâques

14 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric-Paul Pâques Germany 8 405 360 231 161 144 14 722
EG Levin United States 9 404 1.0× 414 1.1× 168 0.7× 115 0.7× 99 0.7× 16 663
Malou Philips Denmark 12 281 0.7× 295 0.8× 121 0.5× 66 0.4× 89 0.6× 16 537
B Wiman Sweden 7 421 1.0× 304 0.8× 157 0.7× 44 0.3× 188 1.3× 11 644
Urszula Kralisz Poland 8 84 0.2× 325 0.9× 255 1.1× 154 1.0× 91 0.6× 18 729
GA Jamieson United States 9 66 0.2× 305 0.8× 166 0.7× 62 0.4× 56 0.4× 9 569
Pauline F. Marx Netherlands 16 212 0.5× 579 1.6× 246 1.1× 20 0.1× 207 1.4× 27 891
Zoe Serefoglou Greece 19 396 1.0× 107 0.3× 241 1.0× 43 0.3× 47 0.3× 26 814
Huimiao Jiang United States 4 108 0.3× 248 0.7× 224 1.0× 32 0.2× 48 0.3× 5 527
M Zushi Japan 9 130 0.3× 622 1.7× 185 0.8× 24 0.1× 60 0.4× 10 853
M. Voskuilen Netherlands 15 198 0.5× 219 0.6× 107 0.5× 33 0.2× 333 2.3× 21 576

Countries citing papers authored by Eric-Paul Pâques

Since Specialization
Citations

This map shows the geographic impact of Eric-Paul Pâques's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric-Paul Pâques with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric-Paul Pâques more than expected).

Fields of papers citing papers by Eric-Paul Pâques

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric-Paul Pâques. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric-Paul Pâques. The network helps show where Eric-Paul Pâques may publish in the future.

Co-authorship network of co-authors of Eric-Paul Pâques

This figure shows the co-authorship network connecting the top 25 collaborators of Eric-Paul Pâques. A scholar is included among the top collaborators of Eric-Paul Pâques based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric-Paul Pâques. Eric-Paul Pâques is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Römisch, Jürgen, et al.. (1995). Investigation of Activated Prothrombin Complex Concentrate as Potential Hirudin Antidote in Animal Models. Pathophysiology of Haemostasis and Thrombosis. 25(4). 182–192. 17 indexed citations
2.
Römisch, Jürgen, et al.. (1994). Inhibition of In Vitro Clot Growth by r-Hirudin Is More Effective and Longer Sustained than by an Analogous Peptide. Thrombosis and Haemostasis. 71(3). 320–324. 2 indexed citations
3.
Bastian, Boris C., et al.. (1993). Inhibition of Human Skin Phospholipase A2 by “Lipocortins” Is an Indirect Effect of Substrate/Lipocortin Interaction. Journal of Investigative Dermatology. 101(3). 359–363. 24 indexed citations
4.
Römisch, Jürgen, et al.. (1993). Comparison of in vitro and in vivo Properties of rHirudin (HBW 023) and a Synthetic Analogous Peptide. Pathophysiology of Haemostasis and Thrombosis. 23(5). 249–258. 17 indexed citations
5.
Dickneite, Gerhard & Eric-Paul Pâques. (1993). Reduction of Mortality with Antithrombin III in Septicemic Rats: A Study of Klebsiella pneumoniae Induced Sepsis. Thrombosis and Haemostasis. 69(2). 98–102. 53 indexed citations
6.
Pâques, Eric-Paul, Melitta Just, Gerald Reiner, & Jürgen Römisch. (1992). Pharmacological and pharmacokinetic properties of a deglycosylated mutant of the tissue-type plasminogen activator expressed in CHO cells. Fibrinolysis and Proteolysis. 6(2). 125–130. 7 indexed citations
7.
Pâques, Eric-Paul, Hermann Erich Karges, & Jürgen Römisch. (1992). Prevention of fibrinogenolysis without impairment of thrombolysis: Combination of A Plasminogen Activator with a2-antiplasmin. Fibrinolysis and Proteolysis. 6(2). 111–117. 1 indexed citations
8.
Heimburger, N., Eric-Paul Pâques, & Jürgen Römisch. (1992). Coagulation and fibrinolysis in cancer.. PubMed. 169–82. 4 indexed citations
9.
Römisch, Jürgen, et al.. (1992). Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction.. PubMed. 3(1). 11–7. 68 indexed citations
10.
Nimtz, Manfred, et al.. (1990). Carbohydrate structures of a human tissue plasminogen activator variant expressed in recombinant Chinese hamster ovary cells. FEBS Letters. 271(1-2). 14–18. 40 indexed citations
11.
Declerck, Paul, M De Mol, Marie‐Christine Alessi, et al.. (1988). Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).. Journal of Biological Chemistry. 263(30). 15454–15461. 401 indexed citations
12.
Pâques, Eric-Paul, Nancy L. Haigwood, Guy T. Mullenbach, et al.. (1988). 280 Mutants of human tissue-plasminogen activator with improved properties in vitro. Fibrinolysis and Proteolysis. 2. 123–123. 2 indexed citations
13.
14.
Pâques, Eric-Paul. (1986). Streptokinase or Urokinase: The Choice between Them. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 3). 21–24. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by EG Levin Breakdown of academic impact, for papers by Malou Philips Breakdown of academic impact, for papers by B Wiman Breakdown of academic impact, for papers by Urszula Kralisz Breakdown of academic impact, for papers by GA Jamieson Breakdown of academic impact, for papers by Pauline F. Marx Breakdown of academic impact, for papers by Zoe Serefoglou Breakdown of academic impact, for papers by Huimiao Jiang Breakdown of academic impact, for papers by M Zushi Breakdown of academic impact, for papers by M. Voskuilen
Rankless by CCL
2026